Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
Become a Member | Sign in
Home>News>This Article

Last Days of the Early Bird Pricings for Biologics World China 2012

Published: Monday, September 24, 2012
Last Updated: Monday, September 24, 2012
Bookmark and Share
Keep up to date with China’s changing biopharma landscape by registering for Biologics World China 2012.

In the last few weeks three major joint ventures have been announced between international pharma’s and Chinese pharma’s. Merck & Co. will be working with Simcere, Pfizer is partnering with Hisun while AstraZeneca will be working with WuXi Appatec to develop and commercialize MEDI5117, a biologic for rheumatoid arthritis.

Giving us an insight into both big pharma and China will be AstraZeneca’s head of the China Biologics Innovation Center Jaiwen Han at Biologics World China 2012.

Biologics World China 2012  will be held on 5-7 November 2012 at Radisson Blu Hotel Pudong Century Park in Shanghai, China.

Organizations that are already confirmed attending include:
•    3S Bio
•    Acertus Pharma LLC
•    Bayer Pharma
•    BD Bioscience
•    BeiGene
•    Beijing Mab-Works
•    Beijing Triprime Genetic Engineering Co. Ltd.
•    Boehringer Ingelheim
•    BravoBio
•    Bristol-Myers Squibb
•    China Biologic Products
•    Chinese-Taipei Biotechnology Service Association
•    Citibank
•    Gan&Lee Pharmaceuticals
•    Genor BioPharma
•    Huabei Organization New Drug Development Company
•    HUYA Bioscience International
•    Innovent Biologics
•    Jiangsu Simcere Pharmaceutical R&D Co. Ltd
•    June He Law Offices
•    King Lai
•    Merck & Co.
•    Merck Millipore
Be heard, be seen by China's biologics industry!

Limited sponsorship and exhibition opportunities

If you have technologies, services or consulting expertise to offer to China’s Biopharma industry, it's your opportunity to act now!

Sartorius Stedim Biotech, Merck Millipore, Boehringer Ingelheim, TAP Biosystems, King Lai and BD Bioscience are already on board to showcase their capabilities at Biologics World China 2012.

Don't be the one to miss out! This unique and targeted biologics platform will be your one stop solution to reach out to the booming Chinese biopharma market!

80% of the exhibition and sponsorship opportunities have been sold and only very few showcase opportunities left!

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

IMAPAC to Bring Together Over 150 Leading Industry Players
IMAPAC’s 3rd Biologics Korea gathering from 22-24 April 2014 in Seoul, Korea.
Wednesday, February 19, 2014
Regional Health Authorities to Meet and Discuss Russia’s 2020 Vision
Government aims for 50% of sold drugs to be manufactured in Russia by 2020.
Thursday, September 05, 2013
Top Biologic Industry Leaders to Convene at Biologics World Korea 2013
Bringing together biologics drug innovators and bioprocess professionals from all around the world to discuss strategies in biosimilar and biobetter development, as well as cutting-edge advances in bioprocessing and bioanalytics.
Friday, December 07, 2012
The Movement of China's Burgeoning Biologics Market
Facilitate innovation and manufacturing of affordable and high quality biologic drugs and vaccines in China.
Friday, August 24, 2012
Scientific News
"Good" Mozzie Virus Might Hold Key to Fighting Human Disease
Australian scientists have discovered a new virus carried by one of the country’s most common pest mosquitoes.
World’s First Therapeutic Venom Database
Open-source library describes nearly 43,000 effects on the human body.
Speeding Up the Process of Making Vaccines
System uses a freeze-dry concept to develop "just-add-water" solution.
Surprising Trait Found in Anti-HIV Antibodies
Scientists at The Scripps Research Institute (TSRI) have new weapons in the fight against HIV.
New Method Identifies Up to Twice as Many Proteins and Peptides
An international team of researchers developed a method that identifies up to twice as many proteins and peptides in mass spectrometry data than conventional approaches.
The Do’s and Don’ts of SPR Experiments
Surface Plasmon Resonance (SPR) is a technique that is becoming more widely used, particularly by anyone who wants to obtain accurate on (association) and off (dissociation) rates for biomolecular binding.
Genetically Engineering Algae to Kill Cancer Cells
New interdisciplinary research has revealed the frontline role tiny algae could play in the battle against cancer, through the innovative use of nanotechnology.
Novel Stem Cell Line Avoids Risk of Introducing Transplanted Tumors
Progenitor cells might eventually be used to repair or rebuild damaged or destroyed organs.
Single Vaccine for Chikungunya, Related Viruses May be Possible
What if a single vaccine could protect people from infection by many different viruses? That concept is a step closer to reality.
Blocking the Transmission Of Malaria Parasites
Vaccine candidate administered for the first time in humans in a phase I clinical trial led by Oxford University’s Jenner Institute, with partners Imaxio and GSK.

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos